Ignite Creation Date:
2024-05-06 @ 2:12 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01998399
Status:
TERMINATED
Last Update Posted:
2017-12-11
First Post:
2013-11-15
Brief Title:
Ticagrelor in Severe Community Acquired Pneumonia
Sponsor:
Gordon Bernard
Organization:
Vanderbilt University Medical Center
Study Overview
Official Title:
Randomized Trial of Ticagrelor for Severe Community Acquired Pneumonia
Status:
TERMINATED
Status Verified Date:
2017-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
poor enrollment unable to meet recruitment goals
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TCAP
Brief Summary:
The purpose of this study is to determine if the drug ticagrelor will be an effective treatment for patients with severe community acquired pneumonia The primary objective is to reduce all-cause mortality in the ticagrelor group compared to the placebo group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None